Bedaquiline

Bedaquiline upsc notes
  Source: The Wire
  Context
    A significant breakthrough
      An agreement 
        reached between
          Nonprofit Global Drug Facility
          Johnson & Johnson
        Distribution of generic versions of bedaquiline
          In most low and middle-income countries
  About TB
    Caused by bacteria
    Primarily affects the lungs
      Can also impact other parts of the body
    Spreads through the air
      When an infected person coughs or sneezes
    A treatable but deadly infectious disease
      Causes 1.5 million deaths annually
    Treatment
      Bedaquiline has shown high success
        In treating drug-resistant TB
      Patent held by Johnson & Johnson
  Significance of the agreement
    Affordable access to the drug
      Enabled by the agreement
      Generic manufacturers in India expected to offer at an 80% lower price
    Goal
      To end TB
      Tender for bedaquiline to be launched soon
    Improved accessibility and affordability of the drug
      Brings hope for global efforts to eliminate TB by 2030
  About Global Drug Facility (GDF)
    A non-profit organization
    Implements the UN-backed ‘The Stop TB Partnership’
      To facilitate global access to quality-assured, affordable TB diagnostics and treatments
  About Stop TB Partnership
    Founded in 2001
    A UN-hosted organization
    Brings together expertise
      From a broad spectrum of partners
        Country partners
        Regional partners
        Global partners
    Shared mission to end TB by 2030
    Hosted and administered by United Nations Office for Project Services (UNOPS)
      In Geneva, Switzerland

Related Posts

If you like this post, please share your feedback in the comments section below so that we will upload more posts like this.

Responses

🖍️ Highlight
HomeCoursesPlansAccount